A form of skin cancer driven by melanocytes, with rising treatment advances and sun-related risk.
A roundup of recent cancer breakthroughs highlights new immunotherapies, targeted drugs and surgical-sparing treatments. The Independent reports on Scolyer’s pioneering work and a landmark NICE decision; The Guardian covers durvalumab’s promise in bladder cancer; Business Insider UK and Reuters summarize ASCO findings on pancreatic and colon cancers, among others.
Five or more sunburns raise melanoma risk by up to 80%, with age and burn severity shaping outcomes. Experts urge daily sunscreen and preventive care as cases rise across the United States.